361 citations
- University of California, Los AngelesUS8 papers
- Stanford UniversityUS6 papers
- Icahn School of Medicine at Mount SinaiUS4 papers
- University of California, San FranciscoUS4 papers
- University of EdinburghGB4 papers
- Cedars-Sinai Smidt Heart InstituteUS3 papers
- Child Health and Development InstituteUS3 papers
- Shahid Beheshti University of Medical SciencesIR3 papers
- The Queen's Medical Research InstituteGB3 papers
- University of WashingtonUS3 papers
- Brigham Young UniversityUS2 papers
- Columbia UniversityUS2 papers
Showing stat.MEShow all
3 papers · 1 filter
stat.ME2023★ 2 cited
Improved inference for MCP-Mod approach for time-to-event endpoints with small sample sizes
Márcio A. Diniz, Diego I. Gallardo, Tiago M. Magalhães
The Multiple Comparison Procedures with Modeling Techniques (MCP-Mod) framework has been recently approved by the U.S. Food and Administration and European Medicines Agency as fit-…
stat.ME2021★ 5 cited
Combining cytotoxic agents with continuous dose levels in seamless phase I-II clinical trials
José L. Jiménez, Mourad Tighiouart
Phase I-II cancer clinical trial designs are intended to accelerate drug development. In cases where efficacy cannot be ascertained in a short period of time, it is common to divid…
stat.ME2011★ 6 cited
Statistical methods for tissue array images - algorithmic scoring and co-training
Donghui Yan, Pei Wang, Michael Linden +2
Recent advances in tissue microarray technology have allowed immunohistochemistry to become a powerful medium-to-high throughput analysis tool, particularly for the validation of d…